First comprehensive computational analysis of functional consequences of TMPRSS2 SNPs in susceptibility to SARS-CoV-2 among different populations A Paniri, MM Hosseini, H Akhavan-Niaki Journal of Biomolecular Structure and Dynamics 39 (10), 3576-3593, 2021 | 100 | 2021 |
Emerging role of IL-6 and NLRP3 inflammasome as potential therapeutic targets to combat COVID-19: Role of lncRNAs in cytokine storm modulation A Paniri, H Akhavan-Niaki Life sciences 257, 118114, 2020 | 82 | 2020 |
Comprehensive in silico identification of impacts of ACE2 SNPs on COVID-19 susceptibility in different populations A Paniri, MM Hosseini, M Moballegh-Eslam, H Akhavan-Niaki Gene reports 22, 100979, 2021 | 36 | 2021 |
Contribution of inflammasome complex in inflammatory-related eye disorders and its implications for anti-inflammasome therapy SA Rasoulinejad, A Karkhah, A Paniri, K Saleki, M Pirzadeh, HR Nouri Immunopharmacology and Immunotoxicology 42 (5), 400-407, 2020 | 24 | 2020 |
Molecular effects and retinopathy induced by hydroxychloroquine during SARS-CoV-2 therapy: Role of CYP450 isoforms and epigenetic modulations A Paniri, MM Hosseini, A Rasoulinejad, H Akhavan-Niaki European journal of pharmacology 886, 173454, 2020 | 20 | 2020 |
Insights into the links between MYC and 3D chromatin structure and epigenetics regulation: implications for cancer therapy F Amjadi-Moheb, A Paniri, H Akhavan-Niaki Cancer research 81 (8), 1925-1936, 2021 | 11 | 2021 |
Alzheimer’s disease-related epigenetic changes: novel therapeutic targets A Paniri, MM Hosseini, H Akhavan-Niaki Molecular Neurobiology 61 (3), 1282-1317, 2024 | 8 | 2024 |
Genetic variations in IKZF3, LET7‐a2, and CDKN2B‐AS1: Exploring associations with metabolic syndrome susceptibility and clinical manifestations A Paniri, MM Hosseini, S Fattahi, G Amiribozorgi, M Asouri, M Maadi, ... Journal of Clinical Laboratory Analysis 38 (1-2), e24999, 2024 | 1 | 2024 |
The epigenetics orchestra of Notch signaling: a symphony for cancer therapy A Paniri, MM Hosseini, F Amjadi-Moheb, R Tabaripour, E Soleimani, ... Epigenomics 15 (24), 1337-1358, 2023 | 1 | 2023 |
Genotype–phenotype association in alpha-thalassemia cohort in a population with high prevalence of alpha and beta-thalassemia: importance of genetic screening A Tamaddoni, H MahmoudiNesheli, A Paniri, M Azizi, A Banihashemi, ... Middle East Journal Of Medical Genetic 10, 24-31, 2021 | 1 | 2021 |
The association of MMUT mutation (NM_000255. 4: C. 976a> g) with wide spectrum clinical manifestations in a child affected with methylmalonic acidaemia YZ Pasha, A Paniri, M Ahmadpour-Kacho, S Fattahi, N Yazarlou, ... New Zealand Journal of Medical Laboratory Science 77 (2), 75-79, 2023 | | 2023 |
A broad spectrum manifestation in a case affected by 3q29 microdeletion syndrome: a literature review and in silico analysis SM Esmaeilnejad-Ganji, A Paniri, M Golpour, R Tabaripour, ... New Zealand Journal of Medical Laboratory Science 76 (3), 157-162, 2022 | | 2022 |
Impact of new UK (B. 1.1. 7) SARS-Cov-2 variant on interacting with ACE2 and host immune response A Paniri, MM Hosseini, H Akhavan-Niaki Gene Reports 25, 101342, 2021 | | 2021 |
A deletion mutation along with a novel DNA variation in OCRL cause Lowe syndrome in a child with multiple secondary manifestations A Paniri, S Fattahi, A Rasoulinejad, H Akhavan-Niaki International Journal of Ophthalmology 14 (4), 636, 2021 | | 2021 |